risk of type 2
diabetes. This variant does not confer sufficient risk to be of clinical
utility on its own. But when measured in addition to our TCF7L2 variant that
is the anchor of the deCODE T2(TM) test, it may, like other common variants
conferring modest risk, enable the test to capture an even larger proportion
of inherited risk. We are currently evaluating its integration into deCODE
T2(TM), because understanding genetic risk of T2D enables individuals and
their physicians to focus, personalize and improve prevention. In the
meantime, we will be enabling our deCODEme subscribers to check their profiles
for this new variant, keeping them at the cutting edge of human genetics,"
said Kari Stefansson, CEO of deCODE.
Type 2 diabetes: A major public health problem
T2D is a chronic condition that develops when the body either becomes
resistant to or doesn't secrete enough insulin. Diabetes affects nearly 200
million people worldwide and, according to the American Diabetes Association,
some 21 million in the United States. The vast majority of these have T2D, and
as many as one third of Americans with diabetes may not even be aware that
they have the disease. More than 50 million Americans have pre-diabetes, a
condition characterized by elevated blood glucose levels and which puts these
individuals at high risk for developing T2D. T2D can be managed and - most
importantly - prevented. If losing weight, eating better and getting adequate
exercise aren't enough, there are also medications that can help to manage
blood sugar levels and insulin response to reduce the likelihood of developing
diabetes. For more information on T2D and how to prevent it, you can go to the
American Diabetes Association's website at http://www.diabetes.org.
About deCODE
deCODE is a bio-pharmaceutical company developing drugs and DNA-based
tests to improve the trea
'/>"/>
SOURCE deCODE genetics Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference2.
deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results3.
deCODE genetics Announces Third Quarter 2007 Financial Results4.
deCODE Launches deCODEme(TM)5.
deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference6.
deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women7.
deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference8.
deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results9.
deCODE Genetics Announces Full-year 2007 Financial Results10.
deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference11.
deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference